Megan Hall

Company: GRAIL

Job title: Distinguished Scientist, VP Corporate Affairs

Seminars:

Multi-Cancer Early Detection: Leveraging a Methylation-Based Platform Across the Cancer Care Continuum 2:00 pm

Addressing the cancer pandemic with multi-cancer early detection The underlying technology, clinical data, and real-world evidence supporting population-scale implementation of a multi-cancer early detection test in cancer screening How the methylation-based platform can be leveraged across the cancer care continuum, including in symptomatic patients and in a post-diagnosis settingRead more

day: Day One